Anti-platelet Therapy and Anticoagulants in ACS Patients – Which? When? Why? – What if I Need to Stop? - Dr. Sukh Nijjer
Simple Education
970 videos
Summary
Sukh Nijjer discusses the various antithrombotic treatments and combinations for ACS patients
- Different anti platelet options - aspirin, PSY12 antagonists, GpIIbIIIa antagonists
- ESC...
Summary
Sukh Nijjer discusses the various antithrombotic treatments and combinations for ACS patients
- Different anti platelet options - aspirin, PSY12 antagonists, GpIIbIIIa antagonists
- ESC guidelines
- Timing of anti platelet therapy - give at the time of making ACS diagnosis
- Pharmacokinetic profiles of the various drugs
- Duration of dual anti platelet therapy
- Stopping DAPT for bleeding or intercurrent surgery
- Bridging strategies
- Anticoagulant therapy - heparin, LMWH, bivalirudin, NOACs
- Co-existing AF and how to treat patients with AF and ACS/PCI
About Simple Education
Simple Education, is a leading provider of coronary physiology and intracoronary imaging courses to aid treatment of complex coronary artery disease.
Speakers
Dr. Nijjer is a Consultant Cardiologist and Senior Clinical Lecturer at Imperial College London. He works at both the...
Dr. Nijjer is a Consultant Cardiologist and Senior Clinical Lecturer at Imperial College London. He works at both the Hammersmith Hospital and Chelsea & Westminster Foundation NHS Trust, as well as leading private Hospitals in London including the Wellington and Cromwell Hospitals. He is the President-elect of the Cardiology Section of the Royal Society of Medicine, and he was selected as an Emerging Leader for the British Cardiovascular Society. He specialises in coronary intervention and focused his clinical practice in the management of ischaemic heart disease. His practice encompasses all aspects of cardiology. In his PhD research, funded by the Medical Research Council (UK) and awarded by Imperial College he developed of new intracoronary physiology techniques, specifically iFR and iFR-pullback and Co-registration. He has published almost 100 peer-reviewed papers in respected journals, including the New England Journal of Medicine and The Lancet. He has also written several books.
Related Videos
Start a conversation